DORMANT studio
localhost:3000

Opportunity radar

4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05

Showing50 of 30,058
Free-text
CPC starts with (comma sep)
Min fwd citations
Clear
Patent #TitleAssetsIssuedExpiresFwd citesScore
12599591Vemurafenib and salts thereof for use in the treatment of enteroviral infections🖼🧊📄§2026-04-142039-10-03031
12599323Methods and systems for treating pregnancy-related hypertensive disorders comprising anti-sEng and anti-sFlt-1 antibodies🖼🧊📄§2026-04-142040-12-08031
12594320Method for treating checkpoint inhibitors induced adverse events🖼🧊📄§2026-04-072040-02-03031
12595307Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors🖼🧊📄§2026-04-072041-06-09031
12594245Dry powder formulations for messenger RNA🖼🧊📄§2026-04-072042-05-16031
12595469Treatment of retinitis pigmentosa using improved engineered meganucleases🖼🧊📄§2026-04-072041-05-11031
12596122LILRB2 antibodies and uses thereof🖼🧊📄§2026-04-072041-01-28031
12595481Methods and compositions for neuroprotection🖼🧊📄§2026-04-072040-11-25031
12594251Benzalkonium chloride foruse in treating conjunctivitis and/or covid-19🖼🧊📄§2026-04-072041-10-14031
12594248Stress management in human subjects in need thereof🖼🧊📄§2026-04-072041-01-13031
12594253HIV inhibitors🖼🧊📄§2026-04-072039-07-24031
12594252Methods for treating inflammatory skin conditions🖼🧊📄§2026-04-072042-06-20031
12594258Inhibitors of MHC-I Nef downmodulation for treating HIV🖼🧊📄§2026-04-072040-12-16031
12594263CBL inhibitors and compositions for expansion of immune cells🖼🧊📄§2026-04-072040-09-23031
12594260Topical formulations for infections🖼🧊📄§2026-04-072044-06-28031
12594270Schizophrenic disorder treatment using combination therapy🖼🧊📄§2026-04-072040-10-21031
12594267Capsid inhibitors for the treatment of HIV🖼🧊📄§2026-04-072044-02-27031
12594271Combination therapy for cancer🖼🧊📄§2026-04-072040-11-05031
12594280Antiviral compositions for treating the flu🖼🧊📄§2026-04-072042-05-31031
12594274Method for preparing a crystalline form of rabeximod🖼🧊📄§2026-04-072041-06-10031
12594281Pharmaceutical dosage forms and methods of use🖼🧊📄§2026-04-072045-05-16031
12594285Compositions and methods for protecting against airborne pathogens and irritants🖼🧊📄§2026-04-072041-10-08031
12594282Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury🖼🧊📄§2026-04-072041-02-26031
12594290IP and IP analogs dosage regimens for the treatment of ectopic calcifications🖼🧊📄§2026-04-072045-02-27031
12594286Immunodulating small molecules🖼🧊📄§2026-04-072042-05-25031
12594289Potentiation of antibiotic effect🖼🧊📄§2026-04-072043-08-11031
12594291Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen🖼🧊📄§2026-04-072039-10-31031
12594294Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation🖼🧊📄§2026-04-072039-12-27031
12594297Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury🖼🧊📄§2026-04-072040-08-03031
12594304Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor🖼🧊📄§2026-04-072043-10-04031
12594310Composition comprising lactic acid bacteria derived from green tea for improving liver function🖼🧊📄§2026-04-072043-05-08031
12594312Bacteriophage compositions for treating Pseudomonas infection🖼🧊📄§2026-04-072041-04-27031
12594311Lactobacillus plantarum PDG8 and use in treating cardiovascular diseases🖼🧊📄§2026-04-072043-05-24031
12594315Use of Liriodendron chinense (Hemsl.) Sarg. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy🖼🧊📄§2026-04-072040-10-23031
12594321Bispecific chimeric antigen receptor that binds CD19 and CD20, encoding nucleic acid molecules thereof and methods of use thereof to treat cancer🖼🧊📄§2026-04-072043-12-05031
12594319Pharmaceutical development🖼🧊📄§2026-04-072040-07-28031
12594325Interleukin-18 variants and methods of use🖼🧊📄§2026-04-072044-11-08031
12594323Methods of reducing neuroinflammation🖼🧊📄§2026-04-072043-04-13031
12594338Cisplatin analogue with potent anti-cancer effects and synthesis thereof🖼🧊📄§2026-04-072043-07-27031
12594334ETAR antibody, and pharmaceutical compositions and use thereof🖼🧊📄§2026-04-072043-01-17031
12594341Multifunctional immunotherapeutic monoclonal antibody complexes and conjugates🖼🧊📄§2026-04-072041-06-14031
12594343Treatment of cancer🖼🧊📄§2026-04-072041-01-28031
12594344Production of exosomes and uses thereof🖼🧊📄§2026-04-072042-12-02031
12594348Compositions for treating Friedreich's ataxia🖼🧊📄§2026-04-072040-12-18031
12594259Treatment regimen for the treatment of neurological diseases or conditions🖼🧊📄§2026-04-072040-10-29031
12594257Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers🖼🧊📄§2026-04-072042-06-02031
12594236Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition🖼🧊📄§2026-04-072042-05-18031
12594255Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement🖼🧊📄§2026-04-072042-06-30031
12594335Platinum-based drug-/photosensitizer-loaded protein nanoparticle, and preparation method therefor and application thereof🖼🧊📄§2026-04-072040-07-24031
12594279Composition for preventing or treating TNF-α-related disease, comprising hydroflumethiazide as active ingredient🖼🧊📄§2026-04-072041-11-05031